Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients

Journal of Infectious Diseases

Volumn 202, Issue 6, 2010, Pages 894-898

  Burbelo, Peter D ^a   Kovacs, Joseph A ^b   Ching, Kathryn H ^a   Issa, Alexandra T ^a   Iadarola, Michael J ^a   Murphy, Alison A ^c   Schlaak, Joerg F ^d   Masur, Henry ^b   Polis, Michael A ^c   Kottilil, Shyam ^c  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIBODY P24; HEPATITIS C VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PEGINTERFERON ALPHA2B; PROTEOME; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; EVENING DOSAGE; FUNCTIONAL PROTEOMICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; MORNING DOSAGE; OPEN STUDY; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFRACTORY ANEMIA; RELAPSE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; DRUG MONITORING; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2B; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 77953234812     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/655780     Document Type: Article

References (14)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562.
2. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34:831-837.
3. Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004; 18:2039-2045.
4. Selik RM, Byers RH Jr, Dworkin MS. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002; 29:378-387.
5. Chun S, Sherman KE. Treatment of hepatitis C virus/HIV coinfection. Clin Liver Dis 2005; 9:525-533.
6. Thomas DL, Astemborski J, Vlahov D, et al. Determinants of the quantity of hepatitis C virus RNA. J Infect Dis 2000; 181:844-851.
7. Benhamou Y, Bochet M, Di Martino V, et al; for the Multivirc Group. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999; 30:1054-1058.
8. Mallolas J, Laguno M. Pegylated IFN-alpha2b plus ribavirin for treatment- naive patients coinfected with HCV and HIV. Expert Rev Anti Infect Ther 2008; 6:281-289.
9. Lempicki RA, Polis MA, Yang J, et al. Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J Infect Dis 2006; 193:1172-1177.
10. Burbelo PD, Ching KH, Mattson TL, Light JS, Bishop LR, Kovacs JA. Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems). Biochem Biophys Res Commun 2007; 352:889-895.
11. Burbelo PD, Meoli E, Leahy HP, et al. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology 2008; 5:96.
12. Desombere I, Van Vlierberghe H, Weiland O, et al. Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C. J Med Virol 2007; 79:701-713.
13. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009; 9:235-245.
14. Moir S, Ho J, Malaspina A, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIVinfected viremic individuals. J Exp Med 2008; 205:1797-1805.